Nadolol Tablet
Product Images NDC 59651-252

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nadolol (NDC 59651-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (40 mg (100 Tablets Bottle))

Each tablet contains Nadolol USP 20 mg and is distributed by Aurobindo Pharma USA, Inc. The recommended dosage is described in the accompanying prescribing information. The tablets should be stored in a light-resistant container at controlled room temperature and kept out of reach of children. The product should not be printed over in the designated zone.*

FDA Label Image

Package Label.principal Display Panel (80 mg (100 Tablets Bottle))

FDA Label Image

Nadolol Fig3

The text describes a medication called Nadolol Tablets, USP, with each tablet containing 80 mg of Nadolol. The medication is distributed by Aurobindo Pharma USA, Inc. The usual dosage is provided in the accompanying prescribing information. The tablets should be stored in a tight, light-resistant container at a temperature between 20 to 25°C and protected from light. There is a code (T/DRUGS/19/1993) provided in the text. The medication should be kept out of reach of children. The remaining text is not useful as it appears to be random characters or an error in .*

FDA Label Image

Nadolol Str

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.